克里唑蒂尼
间变性淋巴瘤激酶
医学
碱性抑制剂
癌症研究
肿瘤
病理
基因重排
间充质干细胞
生物
基因
肺癌
遗传学
恶性胸腔积液
作者
James E. Butrynski,David R. D’Adamo,Jason L. Hornick,Paola Dal Cin,Cristina R. Antonescu,Suresh C. Jhanwar,Marc Ladanyi,Marzia Capelletti,Scott J. Rodig,Nikhil H. Ramaiya,Eunice L. Kwak,Jeffrey W. Clark,Keith D. Wilner,James G. Christensen,Pasi A. Jänne,Robert G. Maki,George D. Demetri,Geoffrey I. Shapiro
标识
DOI:10.1056/nejmoa1007056
摘要
The NCI Common Terminology Criteria for Adverse Events v3.0 is a descriptive terminology which can be utilized for Adverse Event (AE) reporting.A grading (severity) scale is provided for each AE term. Components and Organization CATEGORYA CATEGORY is a broad classification of AEs based on anatomy and/or pathophysiology.Within each CATEGORY, AEs are listed accompanied by their descriptions of severity (Grade). Adverse Event TermsAn AE is any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure.An AE is a term that is a unique representation of a specific event used for medical documentation and scientific analyses.Each AE term is mapped to a MedDRA term and code.AEs are listed alphabetically within CATEGORIES.
科研通智能强力驱动
Strongly Powered by AbleSci AI